drugset / Trial / NCT02180997
Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between Solifenacin and Tamsulosin
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to investigate the pharmacokinetic drug interaction between Solifenacin and Tamsulosin in healthy male volunteers.
Timeline
- Start
- 2014-07
- Primary completion
- 2015-03
- Completion
- 2015-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Solifenacin | Small molecule | 10 mg | — |
| Subject | Tamsulosin | Other / unclassified | 0.4 mg | — |